Spreat S, Conroy J W, Jones J C
Woods Services Inc., Langhorne, PA, USA.
Am J Ment Retard. 1997 Jul;102(1):80-5. doi: 10.1352/0895-8017(1997)102<0080:UOPMIO>2.0.CO;2.
Analysis of statewide survey data revealed that 22.5% of individuals with mental retardation who were served by the Oklahoma mental retardation system were receiving antipsychotic medication. Anxiolytic medications were prescribed for 9.3%, and antidepressants were prescribed for 5.9%. Higher levels of medication use were found in institutional settings and Intermediate Care Facility settings.